Anthracycline cardiotoxicity in childhood

Antonio Ruggiero, Vita Ridola, Nadia Puma, Paola Coccia, Francesco Molinari, Gabriella De Rosa, Riccardo Riccardi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

13 Citazioni (Scopus)


Over the last 40 years, a significant advance has been made in the treatment of childhood and adult cancers. However, the increase of the survival rate points out medium- and long-term adverse effects that constitute a serious limitation for the quality of life in adults survived from a childhood cancer. Cardiovascular disease is an important cause of morbidity and mortality in adults treated with chemo- and radiotherapy for childhood cancers. Although some antitumor treatments are potentially cardiotoxic, anthracycline therapy and radiotherapy are mostly responsible for long-term cardiac damage. Anthracycline toxicity is generally limited to the myocardium, while radiation can cause injury to all components of the heart. The purpose of this review is to discuss the mechanisms of action of anthracyclines, their cardiotoxicity, the feasibility of screening, and the prevention of cardiac damage after treatment in childhood.
Lingua originaleEnglish
pagine (da-a)261-281
Numero di pagine21
RivistaPediatric Hematology and Oncology
Stato di pubblicazionePubblicato - 2008


  • cardiotoxicity


Entra nei temi di ricerca di 'Anthracycline cardiotoxicity in childhood'. Insieme formano una fingerprint unica.

Cita questo